TiO2 nanoparticles induce DNA double strand breaks and cell cycle arrest in human alveolar cells. 2015

Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
Institute of Life Sciences, Ahmedabad University, University Road, Navrangpura, Ahmedabad, Gujarat, India.

TiO2 nanoparticles (NPs) have the second highest global annual production (∼3000 tons) among the metal-containing NPs. These NPs are used as photocatalysts for bacterial disinfection, and in various other consumer products including sunscreen, food packaging, therapeutics, biosensors, surface cleaning agents, and others. Humans are exposed to these NPs during synthesis (laboratory), manufacture (industry), and use (consumer products, devices, medicines, etc.), as well as through environmental exposures (disposal). Hence, there is great concern regarding the health effects caused by exposure to NPs and, in particular, to TiO2 NPs. In the present study, the genotoxic potential of TiO2 NPs in A549 cells was examined, focusing on their potential to induce ROS, different types of DNA damage, and cell cycle arrest. We show that TiO2 NPs can induce DNA damage and a corresponding increase in micronucleus frequency, as evident from the comet and cytokinesis-block micronucleus assays. We demonstrate that DNA damage may be attributed to increased oxidative stress and ROS generation. Furthermore, genomic and proteomic analyses showed increased expression of ATM, P53, and CdC-2 and decreased expression of ATR, H2AX, and Cyclin B1 in A549 cells, suggesting induction of DNA double strand breaks. The occurrence of double strand breaks was correlated with cell cycle arrest in G2/M phase. Overall, the results indicate the potential for genotoxicity following exposure to these TiO2 NPs, suggesting that use should be carefully monitored.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D011650 Pulmonary Alveoli Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. Alveoli, Pulmonary,Alveolus, Pulmonary,Pulmonary Alveolus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014025 Titanium A dark-gray, metallic element of widespread distribution but occurring in small amounts with atomic number, 22, atomic weight, 47.867 and symbol, Ti; specific gravity, 4.5; used for fixation of fractures.
D015162 Micronucleus Tests Induction and quantitative measurement of chromosomal damage leading to the formation of micronuclei (MICRONUCLEI, CHROMOSOME-DEFECTIVE) in cells which have been exposed to genotoxic agents or IONIZING RADIATION. Micronucleus Assays,Assay, Micronucleus,Assays, Micronucleus,Micronucleus Assay,Micronucleus Test,Test, Micronucleus,Tests, Micronucleus
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D053768 Metal Nanoparticles Nanoparticles produced from metals whose uses include biosensors, optics, and catalysts. In biomedical applications the particles frequently involve the noble metals, especially gold and silver. Metal Nanocrystals,Metallic Nanocrystals,Metallic Nanoparticles,Metal Nanocrystal,Metal Nanoparticle,Metallic Nanocrystal,Metallic Nanoparticle,Nanocrystal, Metal,Nanocrystal, Metallic,Nanocrystals, Metal,Nanocrystals, Metallic,Nanoparticle, Metal,Nanoparticle, Metallic,Nanoparticles, Metal,Nanoparticles, Metallic

Related Publications

Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
May 2023, Molecular medicine (Cambridge, Mass.),
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
January 2015, Journal of toxicology,
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
January 2016, Oncotarget,
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
January 1997, The EMBO journal,
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
August 2013, Marine drugs,
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
May 2007, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
January 2010, Nanotechnology,
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
June 1980, Radiation research,
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
July 1998, Genetics,
Krupa Kansara, and Pal Patel, and Darshini Shah, and Ritesh K Shukla, and Sanjay Singh, and Ashutosh Kumar, and Alok Dhawan
January 2023, Genes to cells : devoted to molecular & cellular mechanisms,
Copied contents to your clipboard!